News

Company hires CRO & pharma veteran, Dr. Darren Warren, as new Chief Operating Officer.

Researchers have designed and tested a series of plasmonic nanoantenna arrays that could lead to the development of a new generation of ultrasensitive and low-cost fluorescence sensors that could be used to monitor water quality.

Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.

Scientists at Newcastle University have developed a new method to grow curved human corneas improving the quality and transparency - solely by controlling the behaviour of cells in a dish.

A new report estimates that about 2 million people could be exposed to high levels of naturally occurring arsenic in their water.

A multidisciplinary group has developed a novel platform to diagnose infectious disease at the point-of-care, using a smartphone as the detection instrument in conjunction with a test kit in the format of a credit card.

Researchers have developed the first 3D spatial visualization tool for mapping "'omics" data onto whole organs.

Researchers have determined the crystal structure of a specific dopamine receptor called D4 at an incredibly high resolution which is a major step towards designing improved psychiatric drugs with fewer side effects.

Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.